Core Viewpoint - WeiSi Medical (688580) experienced a decline in stock price, closing at 55.27 yuan on February 6, 2026, down 1.85% with significant net outflows from major funds [1] Group 1: Stock Performance and Trading Data - On February 6, 2026, the stock had a turnover rate of 1.52%, with a trading volume of 14,600 shares and a total transaction value of 80.96 million yuan [1] - Major funds saw a net outflow of 16.78 million yuan, accounting for 20.72% of the total transaction value, while retail investors had a net inflow of 16.84 million yuan, representing 20.80% of the total [1] - Over the past five days, the stock's closing prices and changes were as follows: - February 6: 55.27 yuan, -1.85% - February 5: 56.31 yuan, -1.57% - February 4: 57.21 yuan, +1.92% - February 3: 56.13 yuan, +2.13% - February 2: 54.96 yuan, -0.83% [1] Group 2: Financing and Margin Trading - On February 6, 2026, the financing buy amounted to 11.77 million yuan, while financing repayment was 13.08 million yuan, resulting in a net repayment of 1.31 million yuan [1] - The margin trading balance stood at 230 million yuan, with a margin sell of 200 shares and a margin repayment of 2,500 shares [2] Group 3: Company Financials and Industry Comparison - WeiSi Medical's total market capitalization is 5.293 billion yuan, with a net asset value of 1.658 billion yuan and a net profit of 102 million yuan [4] - The company reported a gross margin of 66.86% and a net margin of 31.38%, significantly higher than the industry averages of 50.55% and 9.59%, respectively [4] - For the first three quarters of 2025, the company achieved a main business revenue of 326 million yuan, a year-on-year increase of 11.58%, and a net profit of 102 million yuan, up 30.68% year-on-year [4] Group 4: Analyst Ratings - In the last 90 days, five institutions provided ratings for WeiSi Medical, with two buy ratings and three hold ratings [5]